Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.20.6.499

Targeting Nrf2-Mediated Gene Transcription by Triterpenoids and Their Derivatives  

Loboda, Agnieszka (Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University)
Rojczyk-Golebiewska, Ewa (Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University)
Bednarczyk-Cwynar, Barbara (Department of Organic Chemistry, Faculty of Pharmacy, University of Medical Sciences)
Zaprutko, Lucjusz (Department of Organic Chemistry, Faculty of Pharmacy, University of Medical Sciences)
Jozkowicz, Alicja (Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University)
Dulak, Jozef (Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University)
Publication Information
Biomolecules & Therapeutics / v.20, no.6, 2012 , pp. 499-505 More about this Journal
Abstract
Chemoprevention represents a strategy designed to protect cells or tissues against various carcinogens and carcinogenic metabolites derived from exogenous or endogenous sources. Recent studies indicate that plant-derived triterpenoids, like oleanolic acid, may exert cytoprotective functions via regulation of the activity of different transcription factors. The chemopreventive effects may be mediated through induction of the nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor. Activation of Nrf2 by triterpenoids induces the expression of phase 2 detoxifying and antioxidant enzymes such as NAD(P)H quinone oxidoreductase 1 (NQO1) and heme oxygenase-1 (HO-1) - proteins which can protect cells or tissues against various toxic metabolites. On the other hand, inhibition of other transcription factors, like NF-${\kappa}B$ leads to the decrease in the pro-inflammatory gene expression. Moreover, the modulation of microRNAs activity may constitute a new mechanism responsible for valuable effects of triterpenoids. Recently, based on the structure of naturally occurring triterpenoids and with involvement of bioinformatics and computational chemistry, many synthetic analogs with improved biological properties have been obtained. Data from in vitro and in vivo experiments strongly suggest synthetic derivatives as promising candidates in the chemopreventive and chemotherapeutic strategies.
Keywords
Anti-oxidant response; Betulin; Chemoprevention; Oleanolic acid; Triterpenoids;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Giudice, A., Arra, C. and Turco, M. C. (2010) Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol. Biol. 647, 37-74.   DOI   ScienceOn
2 Gupta, M. B., Bhalla, T. N., Gupta, G. P., Mitra, C. R. and Bhargava, K. P. (1969) Anti-inflammatory activity of natural products. I. Triterpenoids. Eur. J. Pharmacol. 6, 67-70.   DOI
3 Huang, H. C., Nguyen, T. and Pickett, C. B. (2002) Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277, 42769-42774.   DOI   ScienceOn
4 Jutooru, I., Chadalapaka, G., Abdelrahim, M., Basha, M. R., Samudio, I., Konopleva, M., Andreeff, M. and Safe, S. (2010) Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Mol. Pharmacol. 78, 226-236.   DOI
5 Kaidery, N. A., Banerjee, R., Yang, L., Smirnova, N. A., Hushpulian, D. M., Liby, K. T., Williams, C. R., Yamamoto, M., Kensler, T. W., Ratan, R. R., Sporn, M. B., Beal, M. F., Gazaryan, I. G. and Thomas, B. (2012) Targeting Nrf2-Mediated Gene Transcription by Extremely Potent Synthetic Triterpenoids Attenuate Dopaminergic Neurotoxicity in the MPTP Mouse Model of Parkinson's Disease. Antioxid. Redox Signal. Epub ahead of print.
6 Karius, T., Schnekenburger, M., Dicato, M. and Diederich, M. (2012) MicroRNAs in cancer management and their modulation by dietary agents. Biochem. Pharmacol. 83, 1591-1601.   DOI
7 Kwak, M. K. and Kensler, T. W. (2010) Targeting NRF2 signaling for cancer chemoprevention. Toxicol. Appl. Pharmacol. 244, 66-76.   DOI
8 Li, W. and Kong, A. N. (2009) Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48, 91-104.   DOI
9 Li, Y., Kong, D., Wang, Z. and Sarkar, F. H. (2010) Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res. 27, 1027-1041.   DOI
10 Liby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., Gribble, G. W., Hill-Kapturczak, N., Agarwal, A. and Sporn, M. B. (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65, 4789-4798.   DOI
11 Liby, K., Risingsong, R., Royce, D. B., Williams, C. R., Yore, M. M., Honda, T., Gribble, G. W., Lamph, W. W., Vannini, N., Sogno, I., Albini, A. and Sporn, M. B. (2008) Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268. Clin. Cancer Res. 14, 4556-4563.   DOI
12 Liby, K., Royce, D. B., Williams, C. R., Risingsong, R., Yore, M. M., Honda, T., Gribble, G. W., Dmitrovsky, E., Sporn, T. A. and Sporn, M. B. (2007a) The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res. 67, 2414-2419.   DOI
13 Liby, K. T., Royce, D. B., Risingsong, R., Williams, C. R., Maitra, A., Hruban, R. H. and Sporn, M. B. (2010) Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. Cancer Prev. Res. (Phila) 3, 1427-1434.   DOI
14 Liby, K. T., Yore, M. M. and Sporn, M. B. (2007b) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 7, 357-369.   DOI
15 Liu, J., Liu, Y., Mao, Q. and Klaassen, C. D. (1994) The effects of 10 triterpenoid compounds on experimental liver injury in mice. Fundam. Appl. Toxicol. 22, 34-40.   DOI   ScienceOn
16 Mengoni, F., Lichtner, M., Battinelli, L., Marzi, M., Mastroianni, C. M., Vullo, V. and Mazzanti, G. (2002) In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells. Planta Med. 68, 111-114.   DOI
17 Liu, J., Wu, Q., Lu, Y. F. and Pi, J. (2008) New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction. Biochem. Pharmacol. 76, 922-928.   DOI
18 Liu, X., Jutooru, I., Lei, P., Kim, K., Lee, S. O., Brents, L. K., Prather, P. L. and Safe, S. (2012) Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer. Mol. Cancer Ther. 11, 1421-1431.   DOI
19 Loboda, A., Jazwa, A., Grochot-Przeczek, A., Rutkowski, A. J., Cisowski, J., Agarwal, A., Jozkowicz, A. and Dulak, J. (2008) Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 10, 1767-1812.   DOI   ScienceOn
20 Mu, X., Shi, W., Sun, L., Li, H., Jiang, Z. and Zhang, L. (2012) Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation. Molecules 17, 6854-6868.   DOI
21 Najid, A., Simon, A., Cook, J., Chable-Rabinovitch, H., Delage, C., Chulia, A. J. and Rigaud, M. (1992) Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett. 299, 213-217.   DOI   ScienceOn
22 Neymotin, A., Calingasan, N. Y., Wille, E., Naseri, N., Petri, S., Damiano, M., Liby, K. T., Risingsong, R., Sporn, M., Beal, M. F. and Kiaei, M. (2011) Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 51, 88-96.   DOI
23 Pi, J., Bai, Y., Reece, J. M., Williams, J., Liu, D., Freeman, M. L., Fahl, W. E., Shugar, D., Liu, J., Qu, W., Collins, S. and Waalkes, M. P. (2007) Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 42, 1797-1806.   DOI
24 Nichols, D. P., Ziady, A. G., Shank, S. L., Eastman, J. F. and Davis, P. B. (2009) The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L828-836.   DOI
25 Petronelli, A., Pannitteri, G. and Testa, U. (2009) Triterpenoids as new promising anticancer drugs. Anticancer Drugs 20, 880-892.   DOI
26 Phillips, D. R., Rasbery, J. M., Bartel, B. and Matsuda, S. P. (2006) Biosynthetic diversity in plant triterpene cyclization. Curr. Opin. Plant Biol. 9, 305-314.   DOI
27 Pitha-Rowe, I., Liby, K., Royce, D. and Sporn, M. (2009) Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN. Invest. Ophthalmol. Vis. Sci. 50, 5339-5347.   DOI
28 Reisman, S. A., Aleksunes, L. M. and Klaassen, C. D. (2009) Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochem. Pharmacol. 77, 1273-1282.   DOI
29 Shin, S., Wakabayashi, J., Yates, M. S., Wakabayashi, N., Dolan, P. M., Aja, S., Liby, K. T., Sporn, M. B., Yamamoto, M. and Kensler, T. W. (2009) Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur. J. Pharmacol. 620, 138-144.   DOI
30 Singh, G. B., Singh, S., Bani, S., Gupta, B. D. and Banerjee, S. K. (1992) Anti-inflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol. 44, 456-458.   DOI
31 Suh, N., Honda, T., Finlay, H. J., Barchowsky, A., Williams, C., Benoit, N. E., Xie, Q. W., Nathan, C., Gribble, G. W. and Sporn, M. B. (1998) Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 58, 717-723.
32 Speranza, G., Gutierrez, M. E., Kummar, S., Strong, J. M., Parker, R. J., Collins, J., Yu, Y., Cao, L., Murgo, A. J., Doroshow, J. H. and Chen, A. (2012) Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors. Cancer Chemother. Pharmacol. 69, 431-438.   DOI
33 Sporn, M. B., Liby, K. T., Yore, M. M., Fu, L., Lopchuk, J. M. and Gribble, G. W. (2011) New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J. Nat. Prod. 74, 537-545.   DOI
34 Stack, C., Ho, D., Wille, E., Calingasan, N. Y., Williams, C., Liby, K., Sporn, M., Dumont, M. and Beal, M. F. (2010) Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radic. Biol. Med. 49, 147-158.   DOI
35 Sykiotis, G. P. and Bohmann, D. (2010) Stress-activated cap'n'collar transcription factors in aging and human disease. Sci. Signal. 3, re3.   DOI
36 Takagi, K., Park, E. H. and Kato, H. (1980) Anti-inflammatory activities of hederagenin and crude saponin isolated from Sapindus mukorossi Gaertn. Chem. Pharm. Bull. (Tokyo) 28, 1183-1188.   DOI
37 Tokuda, H., Ohigashi, H., Koshimizu, K. and Ito, Y. (1986) Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett. 33, 279-285.   DOI   ScienceOn
38 Wei, Y., Gong, J., Yoshida, T., Eberhart, C. G., Xu, Z., Kombairaju, P., Sporn, M. B., Handa, J. T. and Duh, E. J. (2011) Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury. Free Radic. Biol. Med. 51, 216-224.   DOI
39 Vannini, N., Lorusso, G., Cammarota, R., Barberis, M., Noonan, D. M., Sporn, M. B. and Albini, A. (2007) The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent. Mol. Cancer Ther. 6, 3139-3146.   DOI
40 Was, H., Dulak, J. and Jozkowicz, A. (2010) Heme oxygenase-1 in tumor biology and therapy. Curr. Drug Targets 11, 1551-1570.   DOI
41 Yore, M. M., Liby, K. T., Honda, T., Gribble, G. W. and Sporn, M. B. (2006) The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta. Mol. Cancer. Ther. 5, 3232-3239.   DOI
42 Yoshimi, N., Wang, A., Morishita, Y., Tanaka, T., Sugie, S., Kawai, K., Yamahara, J. and Mori, H. (1992) Modifying effects of fungal and herb metabolites on azoxymethane-induced intestinal carcinogenesis in rats. Jpn. J. Cancer Res. 83, 1273-1278.   DOI
43 Yu, A. L., Lu, C. Y., Wang, T. S., Tsai, C. W., Liu, K. L., Cheng, Y. P., Chang, H. C., Lii, C. K. and Chen, H. W. (2010) Induction of heme oxygenase 1 and inhibition of tumor necrosis factor alpha-induced intercellular adhesion molecule expression by andrographolide in EA.hy926 cells. J. Agric. Food Chem. 58, 7641-7648.   DOI
44 Yu, X. and Kensler, T. (2005) Nrf2 as a target for cancer chemoprevention. Mutat. Res. 591, 93-102.   DOI
45 Yuk, J. E., Lee, M. Y., Kwon, O. K., Cai, X. F., Jang, H. Y., Oh, S. R., Lee, H. K. and Ahn, K. S. (2011) Effects of astilbic acid on airway hyperresponsiveness and inflammation in a mouse model of allergic asthma. Int. Immunopharmacol. 11, 266-273.   DOI
46 Bloom, D. A. and Jaiswal A. K. (2003) Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278, 44675-44682.   DOI   ScienceOn
47 Zeng, X. Y., Wang, Y. P., Cantley, J., Iseli, T. J., Molero, J. C., Hegarty, B. D., Kraegen, E. W., Ye, Y. and Ye, J. M. (2012) Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice. PLoS One 7, e42115.   DOI
48 Ahmad, R., Raina, D., Meyer, C., Kharbanda, S. and Kufe, D. (2006) Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179. J. Biol. Chem. 281, 35764-35769.   DOI
49 Aleksunes, L. M., Goedken, M. J., Rockwell, C. E., Thomale, J., Manautou, J. E. and Klaassen, C. D. (2010) Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J. Pharmacol. Exp. Ther. 335, 2-12.   DOI
50 Begum, S., Sultana, I., Siddiqui, B. S., Shaheen, F. and Gilani, A. H. (2002) Structure and spasmolytic activity of eucalyptanoic acid from Eucalyptus camaldulensis var. obtusa and synthesis of its active derivative from oleanolic acid. J. Nat. Prod. 65, 1939-1941.   DOI
51 Chintharlapalli, S., Papineni, S., Abdelrahim, M., Abudayyeh, A., Jutooru, I., Chadalapaka, G., Wu, F., Mertens-Talcott, S., Vanderlaag, K., Cho, S. D., Smith, R. 3rd and Safe, S. (2009) Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int. J. Cancer. 125, 1965-1974.   DOI
52 Deeb, D., Gao, X., Liu, Y., Jiang, D., Divine, G. W., Arbab, A. S., Dulchavsky, S. A. and Gautam, S. C. (2011) Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Carcinogenesis 32, 757-764.   DOI
53 Chintharlapalli, S., Papineni, S., Lei, P., Pathi, S. and Safe, S. (2011) Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11, 371.   DOI
54 Ciesla, M., Skrzypek, K., Kozakowska, M., Loboda, A., Jozkowicz, A. and Dulak, J. (2011) MicroRNAs as biomarkers of disease onset. Anal. Bioanal. Chem. 401, 2051-2061.   DOI   ScienceOn
55 Deeb, D., Gao, X., Jiang, H., Janic, B., Arbab, A. S., Rojanasakul, Y., Dulchavsky, S. A. and Gautam, S. C. (2010) Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. Biochem. Pharmacol. 79, 350-360.   DOI
56 Fujiwara, Y., Komohara, Y., Kudo, R., Tsurushima, K., Ohnishi, K., Ikeda, T. and Takeya, M. (2011) Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. Oncol. Rep. 26, 1533-1537.
57 Gao, X., Deeb, D., Hao, J., Liu, Y., Arbab, A. S., Dulchavsky, S. A. and Gautam, S. C. (2010) Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells. Anticancer Res. 30, 785-792.
58 Gao, X., Liu, Y., Deeb, D., Arbab, A. S., Guo, A. M., Dulchavsky, S. A. and Gautam, S. C. (2011) Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-kappaB/mTOR signaling. Anticancer Res. 31, 3673-3681.